Filed: 5/15/2025ACC: 0001420506-25-001276
📋 What this filing means
IKARIAN CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 141 equity positions with a total reported market value of $811.47M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
141
Positions
$811.47M
Total AUM (reported)
50.16M
Total Shares
Allocation by class
COM$522.86M64.4%
TR UNIT$192.99M23.8%
COM NEW$47.18M5.8%
SPONSORED ADS$16.28M2.0%
COMMON STOCK$7.92M1.0%
CLASS A ORD$7.38M0.9%
COM PAR $.01$6.47M0.8%
Portfolio Concentration
Top 3$361.18M44.5%
4–10$130.21M16.0%
11–25$124.50M15.3%
Rest$195.58M24.1%
Top 3 weight
44.5%
Top 10 weight
60.6%
Voting Authority Distribution
Total shares with voting rights: 50.16M
Sole
Full voting authority
50.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole141
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings141
Rows:
SPDR S&P 500 ETF TR
SOLEShares345K
TypeSH
Market value$192.99M
23.78%
Sole
345K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares150K
TypeSH
Market value$123.89M
15.27%
Sole
150K
Shared
0.00
None
0.00
CORCEPT THERAPEUTICS INC
SOLEShares387.90K
TypeSH
Market value$44.31M
5.46%
Sole
387.90K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares746.24K
TypeSH
Market value$25.80M
3.18%
Sole
746.24K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares485.02K
TypeSH
Market value$24.92M
3.07%
Sole
485.02K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares343K
TypeSH
Market value$24.51M
3.02%
Sole
343K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares523.43K
TypeSH
Market value$17.56M
2.16%
Sole
523.43K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares430.09K
TypeSH
Market value$15.57M
1.92%
Sole
430.09K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares344.18K
TypeSH
Market value$11.07M
1.36%
Sole
344.18K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares169.09K
TypeSH
Market value$10.79M
1.33%
Sole
169.09K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares113.90K
TypeSH
Market value$10.08M
1.24%
Sole
113.90K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares245K
TypeSH
Market value$9.92M
1.22%
Sole
245K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares200K
TypeSH
Market value$9.67M
1.19%
Sole
200K
Shared
0.00
None
0.00
TRUPANION INC
SOLEShares240K
TypeSH
Market value$8.94M
1.10%
Sole
240K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares300K
TypeSH
Market value$8.86M
1.09%
Sole
300K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares31.59K
TypeSH
Market value$8.53M
1.05%
Sole
31.59K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares348.20K
TypeSH
Market value$8.37M
1.03%
Sole
348.20K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares210.06K
TypeSH
Market value$8.28M
1.02%
Sole
210.06K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares130K
TypeSH
Market value$8.25M
1.02%
Sole
130K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares276.80K
TypeSH
Market value$7.58M
0.93%
Sole
276.80K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares200K
TypeSH
Market value$7.55M
0.93%
Sole
200K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares189K
TypeSH
Market value$7.38M
0.91%
Sole
189K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares111.60K
TypeSH
Market value$7.32M
0.90%
Sole
111.60K
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares1.07M
TypeSH
Market value$6.92M
0.85%
Sole
1.07M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares400K
TypeSH
Market value$6.84M
0.84%
Sole
400K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 345K | SH | $192.99M 23.78% | 345K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 150K | SH | $123.89M 15.27% | 150K | 0.00 | 0.00 |
CORCEPT THERAPEUTICS INCSOLE | COM | 387.90K | SH | $44.31M 5.46% | 387.90K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 746.24K | SH | $25.80M 3.18% | 746.24K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 485.02K | SH | $24.92M 3.07% | 485.02K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 343K | SH | $24.51M 3.02% | 343K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 523.43K | SH | $17.56M 2.16% | 523.43K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 430.09K | SH | $15.57M 1.92% | 430.09K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 344.18K | SH | $11.07M 1.36% | 344.18K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 169.09K | SH | $10.79M 1.33% | 169.09K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 113.90K | SH | $10.08M 1.24% | 113.90K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 245K | SH | $9.92M 1.22% | 245K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 200K | SH | $9.67M 1.19% | 200K | 0.00 | 0.00 |
TRUPANION INCSOLE | COM | 240K | SH | $8.94M 1.10% | 240K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 300K | SH | $8.86M 1.09% | 300K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 31.59K | SH | $8.53M 1.05% | 31.59K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 348.20K | SH | $8.37M 1.03% | 348.20K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 210.06K | SH | $8.28M 1.02% | 210.06K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 130K | SH | $8.25M 1.02% | 130K | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 276.80K | SH | $7.58M 0.93% | 276.80K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 200K | SH | $7.55M 0.93% | 200K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 189K | SH | $7.38M 0.91% | 189K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 111.60K | SH | $7.32M 0.90% | 111.60K | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 1.07M | SH | $6.92M 0.85% | 1.07M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 400K | SH | $6.84M 0.84% | 400K | 0.00 | 0.00 |
Page 1 of 6
…